Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/69241
Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
BACKGROUND: Regular anti-malarial therapy in pregnancy, a pillar
of malaria control, may affect malaria immunity, with
therapeutic implications in regions of reducing transmission.
METHODS: Plasma antibodies to leading vaccine candidate
merozoite antigens and opsonizing antibodies to
endothelial-binding and placental-binding infected erythrocytes
were quantified in pregnant Melanesian women receiving
sulfadoxine-pyrimethamine (SP) with chloroquine taken once, or
three courses of SP with azithromycin. RESULTS: Malaria
prevalence was low. Between enrolment and delivery, antibodies
to recombinant antigens declined in both groups (p < 0.0001).
In contrast, median levels of opsonizing antibodies did not
change, although levels for some individuals changed
significantly. In multivariate analysis, the malaria prevention
regimen did not influence antibody levels. CONCLUSION: Different
preventive anti-malarial chemotherapy regimens used during
pregnancy had limited impact on malarial-immunity in a
low-transmission region of Papua New Guinea. TRIAL
REGISTRATIONS: NCT01136850.
Subject
Subject (English)
Citation
Collections
Citation
TEO, Andrew, et al. Malaria preventive therapy in pregnancy and its potential impact
on immunity to malaria in an area of declining transmission. Malaria Journal. 2015. Vol. 14, num. 215. ISSN 1475-2875. [consulted: 14 of August of 2026]. Available at: https://hdl.handle.net/2445/69241